Is Veracyte (VCYT) Offering Value After Mixed Returns And Conflicting Valuation Signals [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
If you are wondering whether Veracyte's current share price lines up with its underlying worth, this article walks through the key numbers that matter. The stock last closed at US$33.80, with recent returns of 8.7% over 7 days, 6.2% over 30 days, a 20.3% decline year to date, an 8.5% return over 1 year, a 46.1% return over 3 years, and a 31.6% decline over 5 years. Together, these figures present a mixed picture for anyone thinking about entry or exit points. These moves sit against a backdrop of ongoing interest in Veracyte's role in the US pharmaceuticals and biotech space, with investors watching how its diagnostic offerings position it within that sector. While this article does not focus on short term headlines, that broader context matters when judging whether recent share price shifts align with underlying fundamentals. Veracyte currently has a valuation score of 3 out of 6 . The sections that follow walk through different valuation methods to make sense of that number,
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand [Yahoo! Finance]Yahoo! Finance
- Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026Business Wire
- Veracyte (VCYT) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $45.00 price target on the stock.MarketBeat
- Veracyte (VCYT) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $48.00 price target on the stock.MarketBeat
- Veracyte (VCYT) had its price target lowered by Guggenheim from $50.00 to $45.00. They now have a "buy" rating on the stock.MarketBeat
VCYT
Earnings
- 2/25/26 - Beat
VCYT
Sec Filings
- 4/14/26 - Form 4
- 3/27/26 - Form SCHEDULE
- 3/25/26 - Form 3
- VCYT's page on the SEC website